Cancellation of state registration. Naklofen Protect

February 08, 2018
Active substances:
Trade names:
ICD-10:
XIII.M05-M14.M05    Seropositive rheumatoid arthritis
XIII.M05-M14.M07 *    Psoriatic and enteropathic arthropathies
XIII.M05-M14.M10    Gout
XIII.M15-M19.M15    Polyarthrosis
XIII.M15-M19.M16    Coxarthrosis [arthrosis of the hip joint]
XIII.M15-M19.M17    Gonarthrosis [knee arthrosis]
XIII.M15-M19.M19    Other arthrosis
XIII.M40-M43.M42    Osteocondritis of the spine
XIII.M45-M49.M45    Ankylosing spondylitis
XIII.M50-M54.M54.1    Radiculopathy
XIII.M65-M68.M65    Synovitis and tenosynovitis
XIII.M70-M79.M71    Other bursopathies
Naklofen Protect, diclofenac, lansoprozole, NSAIDs, arthritis, arthrosis, rheumatic soft tissue damage, osteoarthritis

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicines" decided to abolish state registration and exclude from the state register of medicines for the medical use of the medicinal product (registration certificate LP-002077 from 05/28/2013, issued by KRKA-RUS LLC, Russia):

Naklofen Protect (trade name of the medicinal product)

Diclofenac + Lansoprazole (international non-proprietary or chemical name of the medicinal product)

Capsule set: capsules with prolonged release (diclofenac), 75 mg, intestinal-soluble capsuleslansoprazole), 15 mg (dosage form, dosage)

OOO "KRKA-RUS", Russia 143500, Moscow Region, Istra, ul. Moscow, 50 (name and address of the location of the manufacturer of the medicinal product)

on the basis of a representative of the company KRKA-RUS, Russia, by an authorized legal entity, cancellation of state registration of medicinal product.